Centre Algatech

Institute of Michrobiology, Academy of Sciences of the Czech Republic


EU HORIZON 2020 - ALGAE4IBD
– from nature to bedside – algae based bio compound for prevention and treatment of inflammation, pain and IBD
https://cordis.europa.eu/project/id/101000501

 

Registration Number

For Years

Project name

Total Subsidy
(in thousand €)

Popis projektu

N° 101000501, H2020-FNR-2020-2

2021 - 2025

ALGAE4IBD
– from nature to bedside – algae based bio compound for prevention and treatment of inflammation, pain and IBD

Investigators:
Dr. Dorit Avni  (coordinator)
Migal Galilee Research Institute Ltd.


Dr. Pavel Hrouzek
Laboratory of Algal Biotechnology
Institute of Microbiology, CAS

7 500 

Inflammatory bowel disease (IBD), including the Crohn´s disease, is one of the most important civilization disorder nowadays. Algae4IBD’s mission is to discover algal and cyanobacterial bioactive compounds reducing the inflammatory response and simultaneously silencing other IBD symptoms. The biomass of algal strains producing such compound will be used for preparation of functional food used in treatment and prevention of IBD. International consortium led by Israeli colleagues includes scientist from 21 European institutions with different expertise ranging from natural product chemistry, pharmacology, drug administration to functional food preparation.